Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2023-06-14 00:00:00 ET · period of report 2023-06-13 · accession 0001562180-23-005152 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-14 | 2023-06-13 | SNDX | Goldan Keith A. | CFO | S - Sale | $22.31 | -577 | 2,628 | -18% | -$12.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-13 | S | D | 577 | $22.31 | 2,628 | D | — | — |